HEPACAM and renal cell carcinoma: (43), hepaCAM was discovered to arrest RCC cells in the G1 stage of the cell cycle, resulting in cell proliferation suppression, and thus RCC-derived sEVs-mediated downregulation of hepaCAM may be associated with excessive proliferation of RCC cells (42).